In estrogen receptor-positive (ERα+) human breast cancer cells, MEL downregulated both ERα mRNA expression and estrogen-induced transcriptional activity of the ERα through MEL receptors 1 (MT 1)-induced activation of G(αi2) signaling with the consequent reduction of cAMP levels [108]. This evidence concerns the gene ESR1 and breast cancer.